SEC Form 4 · accession 0001246360-17-002524
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Aug 7, 2017
Accepted (ET)
Aug 8, 2017 · 6:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2017 | M | 7,000 | $11.03 | A | 82,903 | D | |
| Common Stock | Aug 7, 2017 | M | 12,000 | $14.66 | A | 94,903 | D | |
| Common Stock | Aug 7, 2017 | M | 2,669 | $18.48 | A | 97,572 | D | |
| Common Stock | Aug 7, 2017 | M | 2,331 | $18.59 | A | 99,903 | D | |
| Common Stock | Aug 7, 2017 | S | 6,000 | $29.66 | D | 93,903 | D | |
| Common Stock | Aug 7, 2017 | S | 18,000 | $29.63 | D | 75,903 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.03 | Aug 7, 2017 | M | 7,000 | D | Apr 4, 2013 | Mar 3, 2023 | Common Stock | 7,000 | 25,897 | D |
| Stock Option (Right to Buy) | $14.66 | Aug 7, 2017 | M | 12,000 | D | Apr 10, 2014 | Mar 9, 2024 | Common Stock | 12,000 | 36,958 | D |
| Stock Option (Right to Buy) | $18.48 | Aug 7, 2017 | M | 2,669 | D | Apr 9, 2012 | Mar 8, 2019 | Common Stock | 2,669 | 7,542 | D |
| Stock Option (Right to Buy) | $18.59 | Aug 7, 2017 | M | 2,331 | D | Jun 27, 2011 | May 26, 2018 | Common Stock | 2,331 | 5,392 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016.